Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 14, 2015; 21(42): 12141-12149
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12141
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12141
Phase of HBV infection | Immune-tolerant | Immune-active (-clearance) | Immune-inactive | Reactivation/HBeAg-negative chronic hepatitis |
HBsAg | Detectable | Detectable | Detectable | Detectable |
HBeAg | Detectable | Detectable | Undetectable (anti-HBe positive) | Undetectable (anti-HBe positive) |
HBV DNA (IU/mL)/(copies/mL) | > 20000/> 105 | > 20000/> 105 | < 2000/< 104 or undetectable | > 2000/> 104 |
ALT | Normal | Persistently elevated | Normal | Normal or elevated |
Histopathology: necroinflammation and fibrosis | Minimal or absent | Can develop | Liver inflammation absent or minimal, fibrosis regresses over time | Active liver inflammation +/- fibrosis |
Liver biopsy | Generally not indicated | Indicated | Generally not indicated | Indicated, especially if ALT elevated |
Antiviral therapy | Generally ineffective, risk of drug resistance; continued monitoring recommended | Should be considered | Continued monitoring recommended | Should be considered if moderate or severe inflammation or fibrosis detected |
- Citation: Pokorska-Śpiewak M, Kowalik-Mikołajewska B, Aniszewska M, Pluta M, Marczyńska M. Is liver biopsy still needed in children with chronic viral hepatitis? World J Gastroenterol 2015; 21(42): 12141-12149
- URL: https://www.wjgnet.com/1007-9327/full/v21/i42/12141.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i42.12141